| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1.291,880042 | 08/07/2026 | 3,18% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A2-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1.095,676955 | 08/07/2026 | 3,23% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1.290,819011 | 08/07/2026 | 3,44% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 798,728516 | 08/07/2026 | 3,44% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 147,790249 | 08/07/2026 | 3,11% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 829,980709 | 08/07/2026 | 3,10% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 137,934058 | 08/07/2026 | 2,84% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 117,695545 | 08/07/2026 | 3,05% | · | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | RVI BIOTECNOLOGÍA | 141,540000 | 30/06/2026 | 20,52% | 55,73% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | RVI BIOTECNOLOGÍA | 930,013118 | 09/07/2026 | 23,14% | 54,16% | *** |
